Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Clasificación en acciones #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Precio por acción
$99.32
Capitalización bursátil
$48.20B
Cambio (1 día)
0.98%
Cambio (1 año)
-32.14%
País
AU
Comercio CSL Limited (CSL)

Categoría

Healthcare
EPS de CSL Limited (CSL)
EPS a fecha de December 2025 TTM: $2.98
Según los últimos informes financieros y el precio de las acciones de CSL Limited, el EPS actual de la empresa (TTM) es $2.98. Al final del año 2024, la empresa tenía un EPS de $5.47 un aumento con respecto a al EPS de 2023, que fue de $4.55.
Historial de EPS de CSL Limited desde 2000 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 21.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 419.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,346.98%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 222.85%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $38.32 1,185.91%
NL